Spot it early, treat it smarter: Targeting type 2 inflammation in childhood AD and asthma
a day ago
During a Sanofi-sponsored discussion, experts discussed the importance of targeting type 2 inflammation in atopic dermatitis (AD) to interrupt the atopic march and mitigate respiratory sequelae such as asthma. Dr Lynn Chiam, a dermatologist at Mount Elizabeth Novena Specialist Medical Centre, Singapore, discussed the impact of AD beyond the skin. Dr Chiang Wen Chin, a paediatric allergy and immunology specialist at Mount Elizabeth Medical Centre Orchard, Singapore, offered insights into managing severe asthma in children. Dr Ong Eng Keow, a paediatrician at Mount Alvernia Hospital, Singapore, chaired the discussion.
Resources
Spot it early, treat it smarter: Targeting type 2 inflammation in childhood AD and asthma